What Happened

The Centers for Disease Control and Prevention (CDC) linked multiple multistate Salmonella outbreaks to moringa supplements in 2026 (Salmonella CDC 2026), and issued public health notices and recall advice to consumers and clinicians. CDC investigations from January through July 2026 tied contaminated moringa leaf powder and moringa capsules from several brands to Salmonella infections, including an extensively drug-resistant (XDR) Salmonella Newport strain carrying an NDM-1 gene in one outbreak; the U.S. Food and Drug Administration (FDA) participated in traceback and regulatory actions for affected products. Public health guidance advises discarding or returning recalled moringa products because supplements have long shelf lives and may still pose exposure risk to users [1] [3] [7].

Why It Matters

These outbreaks address a clinical problem where contaminated dietary supplements act as a vehicle for enteric infection and, in one cluster, an extensively drug-resistant Salmonella strain that limits standard antibiotic choices. Patients who ingest powdered or capsule moringa products are the primary exposed population, and outbreaks were reported across multiple states with public health and regulatory follow-up by CDC, state officials, and FDA [1] [3]. The XDR Salmonella Newport isolate with an NDM-1 gene represents the first documented U.S. outbreak involving that resistance mechanism, meaning empiric oral regimens commonly used for noninvasive Salmonella may be ineffective and clinicians must rely on culture and susceptibility data to guide therapy [5]. The long shelf life of supplements and recent product recalls increase the number of patients who may still possess contaminated lots, so outpatient and inpatient clinicians need updated counseling and testing workflows now that epidemiologic and laboratory links have been established [2] [4].

What Changed

• Previously clinicians might treat uncomplicated gastroenteritis empirically with oral agents when indicated → Now clinicians should obtain stool cultures and blood cultures when Salmonella is suspected and ensure susceptibility testing is performed because XDR isolates have been identified in these outbreaks [5].
• Previously supplement exposure was an occasional screening question → Now asking specifically about moringa leaf powder or moringa capsules consumed within the prior month must be part of the exposure history for patients with gastroenteritis or invasive Salmonella infection [1].
• Previously no widespread consumer advice existed for moringa products → Now CDC and state officials have advised consumers to throw out or return recalled moringa products and FDA has been involved in traceback and recall coordination for affected brands [1].
• Previously reporting of Salmonella isolates to public health was routine but not outbreak-focused → Now laboratories and clinicians should prioritize rapid reporting and submission of isolates to public health labs for molecular typing to support outbreak detection and resistance surveillance [2].
• Previously outpatient counseling often allowed continued supplement use during convalescence → Now patients exposed to recalled moringa products should be advised to discontinue use immediately and dispose of or return products per CDC recall instructions [2].

Sources and Further Reading

[1] Centers for Disease Control and Prevention. Salmonella Outbreak Linked to Moringa Leaf Powder. 1 day ago. URL: https://www.cdc.gov/salmonella/outbreaks/supergreenssupplementpowders-1-26/index.html

[2] Centers for Disease Control and Prevention. Investigation Update: Salmonella Outbreak, January 2026. 1 day ago. URL: https://www.cdc.gov/salmonella/outbreaks/supergreenssupplementpowders-1-26/investigation.html

[3] Centers for Disease Control and Prevention. Extensively Drug-Resistant Salmonella Outbreak Linked to Rosabella Moringa Capsules. Apr 1, 2026. URL: https://www.cdc.gov/salmonella/outbreaks/moringacapsules-02-26/index.html

[4] Centers for Disease Control and Prevention. Investigation Update: Salmonella Outbreak, February 2026. Apr 1, 2026. URL: https://www.cdc.gov/salmonella/outbreaks/moringacapsules-02-26/investigation.html

[5] Centers for Disease Control and Prevention. Clinical Overview of extensively drug-resistant Salmonella (NDM-1). Apr 1, 2026. URL: https://www.cdc.gov/salmonella/hcp/clinical-overview/xdr-salmonella-ndm1.html

[6] Centers for Disease Control and Prevention. Salmonella Outbreak Linked to Moringa Capsules. 6 days ago. URL: https://www.cdc.gov/salmonella/outbreaks/moringa-05-26/index.html

[7] Centers for Disease Control and Prevention. Investigation Update: Salmonella Outbreak, May 2026. July 17, 2026. URL: https://www.cdc.gov/salmonella/outbreaks/moringa-05-26/investigation.html